Is that allowed - To charge the impairment based on data results released on 6th July 2017, when the financial reports are dates ending on 30 Jun 2017. I would think that the impairment would be charged to the next FY results, because at the time of 30th Jun, they wouldn't have known the impact and couldn't calculate the impairment. Not that it matters, but seems to be softening the blow of next year's results.
Genuine curious question.
- Forums
- ASX - By Stock
- ACR
- Ann: Teva Launches Generic Version of Axiron in United States
ACR
acrux limited
Add to My Watchlist
0.00%
!
1.9¢

Ann: Teva Launches Generic Version of Axiron in United States, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.747M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $5.562K | 292.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 381825 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 60000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 331825 | 0.019 |
3 | 381800 | 0.018 |
1 | 175000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 60000 | 2 |
0.021 | 177000 | 1 |
0.022 | 18000 | 1 |
0.023 | 73278 | 3 |
0.024 | 254102 | 7 |
Last trade - 15.04pm 20/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |